Impacts of the COVID-19 pandemic on diagnosis of renal cell carcinoma and disease stage at presentation
CONCLUSIONS: The first year following the COVID-19 pandemic saw an 11.1% increase in patients presenting with pT3 RCC. These findings are suggestive of a clinically significant stage migration, which paired with prolonged wait times for surgery, provide critical consideration in the urgency of diagnostic and treatment decisions for RCC in the immediate future.PMID:38381938 | DOI:10.5489/cuaj.8519
Source: Canadian Urological Association Journal - Category: Urology & Nephrology Authors: W C Ian Janes Mitchell G Fagan J Matthew Andrews David R Harvey Geoff M Warden Paul H Johnston Michael K Organ Source Type: research
More News: Canada Health | Cancer & Oncology | Carcinoma | COVID-19 | International Medicine & Public Health | Kidney Cancer | Nephrectomy | Pandemics | Renal Cell Carcinoma | Study | Urology & Nephrology